Taloporfin (Laserphyrin)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 23:53, 31 July 2023 by Jwarner (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Photosensitizer

Diseases for which it is used

History of changes in PMDA indication

  • 2013-09-20: New additional indication and a new dosage for the treatment of primary malignant brain tumor (only for the case where surgical excision of tumor is performed).
  • 2015-05-26: New additional indication for the treatment of recurrent esophageal cancer associated with local persistence after chemoradiotherapy or radiotherapy.

Also known as

  • Brand name: Laserphyrin
Retrieved from "https://hemonc.org/w/index.php?title=Taloporfin_(Laserphyrin)&oldid=76006"